Literature DB >> 28107367

First Molecular Characterization of Feline Immunodeficiency Virus in Domestic Cats from Mainland China.

Jilei Zhang1, Liang Wang1, Jing Li1, Patrick Kelly2, Stuart Price3, Chengming Wang1,3.   

Abstract

The feline immunodeficiency virus (FIV) is a retrovirus of the Lentivirus genus that was initially isolated from a colony of domestic cats in California in 1986 and has now been recognized as a common feline pathogen worldwide. To date, there is only one recent serology-based report on FIV in mainland China which was published in 2016. We designed this study to investigate the molecular prevalence and diversity of feline immunodeficiency virus (FIV) in domestic cats from mainland China. We studied the prevalence of FIV in whole blood samples of 615 domestic cats in five cities (Beijing, Guangzhou, Nanjing, Shanghai and Yangzhou) of mainland China and examined them using FRET-PCR (Fluorescence Resonance Energy Transfer-Polymerase Chain Reaction) and regular PCRs for the gag and env genes. Overall, 1.3% (8/615) of the cats were positive for provirus DNA with nucleotide analysis using PCRs for the gag and env sequences showing the cats were infected with FIV subtype A. This is the first molecular characterization of FIV in mainland China and the first description of subtype A in continental Asia.

Entities:  

Mesh:

Year:  2017        PMID: 28107367      PMCID: PMC5249086          DOI: 10.1371/journal.pone.0169739

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The feline immunodeficiency virus (FIV) is a retrovirus of the Lentivirus genus that was initially isolated from colony of domestic cats in California in 1986 and has now been recognized as a common feline pathogen worldwide [1-4]. Infected cats may be asymptomatic for many years during which there is progressive disruption of immune function which might lead to a terminal phase with various clinical infections that is referred to as the feline acquired immunodeficiency syndrome [5]. Transmission of FIV is principally by parenteral inoculation of the virus in blood and saliva, presumably during fighting. Male cats are more commonly infected than females and overall prevalence rates in cats vary geographically, mostly from around 2% to 30% [5]. FIV occurs as seven subtypes or clades (A, B, C, D, E, F and U-NZenv) based on nucleotide sequence diversity of the envelope (env) gene [6-9]. The distribution of the clades varies with subtypes A and B being most common, and occurring very widely [8, 10]. Subtype A is common in Australia, New Zealand, the western part of the United States, South Africa and northwestern Europe [8]. Subtype C has been identified in Europe, Africa, Southeast Asia, New Zealand and Canada while subtypes D and E are found only infrequently, originally in Japan, Canada and Argentina [11-14]. Subtype F has only been described from Portugal and the US and the U-NZenv subtype only from New Zealand [7, 9, 15]. There is only limited data on the genotypes of the latter two subtypes. To date, there have been five FIV-related reports in Taiwan [16-20], but only little data on FIV in mainland China. A study on wild Pallas’ cats from China and other Asian countries identified a unique monophyletic lineage of the FIV most closely related to FIV of African wild cats [21-22]. In the only work on domestic cats, a serosurvey using a commercial test kit (SNAP® Feline Triple® Test, IDEXX Laboratories, Westbrook, ME, USA) found 9% (33/362) of cats studied in Lanzhou, northwestern China, were positive [23]. To provide further information on FIV infections we carried out a molecular survey on cats from five areas in mainland China.

Materials and Methods

The study was reviewed and approved by the Institutional Animal Care and Use Committee of the Yangzhou University College of Veterinary Medicine. Between April 2013 and June 2015, whole blood samples were collected from 615 cats in five cities (Beijing, Guangzhou, Nanjing, Shanghai and Yangzhou) in four provinces of mainland China. The cats from Yangzhou were apparently healthy animals in a shelter while those from the other cities were cats presenting to veterinary clinics for routine health examinations and vaccinations and neutering or with a variety of conditions including fever, stomatitis, and renal failure. All blood samples were collected into EDTA-containing tubes and stored at -80°C until DNA extraction. DNA was extracted from whole blood samples with the QIAamp® DNA Blood Mini Kit (QIAgen, Valencia, USA) following the protocol of the manufacturer. A negative control, diethylpyrocarbonate (DEPC)-treated ddH2O, was used for extraction after every 24 blood samples to confirm the absence of carry-over contamination during DNA extraction. The FIV FRET-PCR was performed in a LightCycler 480-II real-time PCR platform as described previously [24]. This PCR method can detect single copies of a 176-bp gag gene fragment of the FIV provirus genome and can be used to differentiate subtypes A to E [24]. Positive controls consisted of nucleotide fragments of the gag regions of FIV subtypes A, B1, B2/E, C and D that were prepared as described previously [24]. Products obtained in the FIV FRET-PCR were further verified by electrophoresis through 2% agarose gels (BIOWEST®, Hong Kong, China), purified with the QIAquick PCR Purification Kit (Qiagen, Germany), and sequenced with forward and reverse primers (BGI Shanghai, China). The env sequences of eight FIV subtypes (sybtype A: M25381, L00607, X69496, D37813, X69694, M36968; subtype A/B: KP330229; subtype B: D37814, U11820; subtype C: AF474246, AY600517; subtype D: D37811, D37815; subtype E: D84496, D84498; subtype F: DQ072566; subtype U: EF153977, GQ357640) (Fig 1) were obtained from GenBank (www.ncbi.nlm.nih.gov/). The Clustal Multiple Alignment Algorithm was used on the V1-V2 and V3-V4 regions common to the env of all the above FIV subtypes to identify polymorphic regions that would enable us to differentiate between subtypes. The primers to amplify the polymorphic regions were synthesized by GenScript (GenScript, Nanjing, China). Standard PCRs were performed with the primers we designed against a 374-bp segment in the V1-V2 region (forward: GAAGAAGGAAATGCAGGTAAGTTTAGAA; reverse: GGTGCCCAACAATCCCAAAA) and a 680-bp segment of V3-V5 (forward: ATACCAAAATGTGGATGGTGGAA; reverse: TAATCCTGCTACTGGGTTATACCAATT). The primers for the V1-V2 region (first segment of the env) amplify subtypes A to E while those for the V3-V5 region (second segment of env) detect all subtypes (A to F and U-NZenv). Positive controls consisted of FIV subtypes A, B and C identified in a previous study [24]. The standard PCRs were performed in a Roche LightCycler II PCR platform. Each reaction was performed with a 20μl final volume containing 10μl of extracted nucleotides, 1×PCR buffer, 1μM forward primer, 1μM reverse primer, 2 unit Taq DNA polymerase and 200μM dNTP. Thermal cycling consisted of 18 high-stringency step-down cycles followed by 30 relaxed-stringency cycles. The cycling parameters for PCR were 6 × 1 sec at 95°C, 12 sec at 72°C, 30 sec at 72°C; 9 × 1 sec at 95°C, 12 sec at 70°C, 30 sec at 72°C; 3 × 1 sec at 95°C, 12 sec at 68°C, 30 sec at 72°C; 30 × 1 sec at 95°C, 8 sec at 56°C, 30 sec at 67°C, 30 sec at 72°C. Products were verified by gel electrophoresis and sequenced with forward and reverse primers using the Sanger method (BGI, Shanghai, China).
Fig 1

Phylogeny of gag and env genes of FIV.

Gag sequences (176-bp) of FIV strains identified in this study and representatives of the five subtypes with sequences in GenBank. In addition, a 374-bp region encompassing V1 to V2 is shown on the left of the bottom panel, and a 502-bp region encompassing V3 to V5 on the right panel. The env sequences of the FIV strains identified in this study (in red) are compared with the sequences of representatives of the FIV subtypes with sequences in GenBank; five for V1 to V2 and seven for V3 to V5. Branch lengths are measured in nucleotide substitutions and numbers show branching percentages in bootstrap replicates. Scale bar represents the percent sequence diversity.

Phylogeny of gag and env genes of FIV.

Gag sequences (176-bp) of FIV strains identified in this study and representatives of the five subtypes with sequences in GenBank. In addition, a 374-bp region encompassing V1 to V2 is shown on the left of the bottom panel, and a 502-bp region encompassing V3 to V5 on the right panel. The env sequences of the FIV strains identified in this study (in red) are compared with the sequences of representatives of the FIV subtypes with sequences in GenBank; five for V1 to V2 and seven for V3 to V5. Branch lengths are measured in nucleotide substitutions and numbers show branching percentages in bootstrap replicates. Scale bar represents the percent sequence diversity. The gag and env sequences we obtained were aligned with similar sequences in GenBank with the Clustalx 1.83 alignment software. Phylogenetic trees were constructed by the neighbor-joining method using the Kimura 2-parameter model with MEGA 6.0. Bootstrap values calculated using 500 replicates.

Results

We analyzed blood samples from 615 cats from Beijing (n = 138), Guangzhou (75), Nanjing (146), Shanghai (143) and Yangzhou (113). Background data was available for 514 cats of which 383 were owned and kept mainly indoors and 131 were strays; 278 were male and 236 were female. Estimated age data was available for 458 cats which were placed into one of the following arbitrary age groups: 68 kittens (< 6 m), 225 young adults (6 m to 4 yrs), 101 adults (4 to 10yrs) and 64 older cats (>10yrs). The FRET-PCR followed by confirmatory sequencing showed that 1.3% (8/615) of the cats were positive for FIV. All the FIV-positive cats were male cats from Guangzhou (n = 1), Shanghai (3) and Nanjing (4) (Table 1). Seven of these 8 FIV-positive cats were sick with clinical signs such as stomatitis, salivation and anorexia. The melting point and the gag sequence analyses of the FRET-PCR showed all the positive sequences belonged to FIV subtype A. They had 97%-99% (2-5/164 nucleotide mismatches) similarity with the FIV subtype A TN7 strain (GQ422127) from Canada, and 97%-98% (2-4/164 mismatches) similarity with a FIV subtype A CaONA07 strain (AY225009) from Canada.
Table 1

FIV-positive cats identified in this study.

CatCityAge (year)GenderSourceHealth status
C18Guangzhou1.0Neutered maleDomestic catRenal failure
C180Nanjing3.0Intact maleFeral catStomatitis
C181Nanjing3.0Intact maleFeral cat before adoptionDepression
C171Nanjing1.5Intact maleFeral cat before adoptionStomatitis
C172Nanjing3.0Intact maleDomestic catStomatitis
C174Shanghai0.25Intact maleDomestic catFever, 41.3°C
C176Shanghai3.0Neutered maleDomestic catFeline calicivirus infection
C78Shanghai10.0Intact maleDomestic catApparently healthy
The sequences of the V1-V2 env region (GenBank accession number: KX710096- KX710097 and KX904827-KX904832) in the positive cats were all similar (90%-97% identity) with six being most closely related to the UK2 strain. This is a FIV subtype A from Scotland (X69494) which has 91% similarity with C18, C172, C176 and C180 (32–34 mismatches) and 93% similarity with C78 and C174 (26 and 28 mismatches, respectively) [25]. In the remaining two positive cats, one (C171) had a strain most closely related to the Sendai1 strain, a FIV subtype A from Japan (D37814) (91% similarity, 32/374), and the other (C181) a strain with 91% similarity to UK2 strain and Sendai1 strain (38/374). (Table 2) [26].
Table 2

Percent similarities (upper-right diagonal half) and actual numbers of mismatches (lower-left diagonal half) in the env V1-V2 sequences (374bp) of two FIV positive cats from China and representatives of the four FIV subtypes with sequences on GenBank.

C18C78C171C172C174C176C180C181UK2Sendai1UK8DixonPetalumaPPRFDSSendai2USILCC36ShizuokaFukuoka
C18a9390939390939291908890898576767365657070
C782792949894949493928992928576757266657170
C1713628939390949290918789888475737166667070
C1722824269491979491918891898477757266667271
C174287252294959493928992928576757266657170
C1763822403422919191908890898477767366657169
C1802822241219349591918891908476747166667271
C1813128322426382191918790898475747267667170
A-UK23328373226343238908891908375747166647069
A-Sendai13829323428383438378891908476747266666967
A-UK84341374340464653444488879076757266666968
A-Dixon3831433531373441343644918476747265647067
A-Petaluma4231464031433846373749348577767466667270
A-PPR5655626156615963656040605776757266656967
A/B-FDS9191958990879398969290928991959468687071
B-Sendai294971029696931011041009996999496199767677070
B-USIL2489103106113107107104111112109108107106102105241266656869
C-C133131131129133133130130133129131136128131126129134956364
C-C36133134132130136136130133137132131140130134124130137206465
D-Shizuoka11411111410711111310711511411910511510512011111411914314392
D-Fukuoka11611411611011611711011811912512012511512511011311814013932

a The GenBank Accession numbers of the China strains are C18(KX710096); C78 (KX710097), C171 (KX904827), C172 (KX904828), C174 (KX904829), C176 (KX904830), C180 (KX904831) and C181 (KX904832), while those of previously reported FIV are: subtype A, UK2 (X69494), Sendai1 (D37813), UK8 (X69496), Dixon (L00607), Petaluma (M25381), PPR (M36968); subtype A/B, FDSydneyC36 (KP330229); subtype B, Sendai2 (D37814), USIL2489 (U11820); subtype C, C (AF474246), C36 (AY600517); subtype D, Shizuoka (D37811), Fukuoka (D37815).

a The GenBank Accession numbers of the China strains are C18(KX710096); C78 (KX710097), C171 (KX904827), C172 (KX904828), C174 (KX904829), C176 (KX904830), C180 (KX904831) and C181 (KX904832), while those of previously reported FIV are: subtype A, UK2 (X69494), Sendai1 (D37813), UK8 (X69496), Dixon (L00607), Petaluma (M25381), PPR (M36968); subtype A/B, FDSydneyC36 (KP330229); subtype B, Sendai2 (D37814), USIL2489 (U11820); subtype C, C (AF474246), C36 (AY600517); subtype D, Shizuoka (D37811), Fukuoka (D37815). The sequences of the env V3-V5 segment amplicons of the eight positive cats (GenBank accession number: KX646706-KX646707 and KX904833-KX904838) differed by 3%-7% (27–53 mismatches) (Table 3). Five were most closely related to the UK2 strain, a FIV subtype A from Scotland (X69496), with 94–95% similarity (38–43 mismatches) to C171, C172, C174, C176 and C180 (Table 3) [19]. The other three positivities were most closely related to FIV subtype A/B strain FDSydneyC36 from Australia (KP330229) which had 94% (636/677) identity with C18, 96% (652/683) identity with C78 and 95% (638/680) identity with C181, respectively (Table 3, Fig 1) [26].
Table 3

Percent similarities (upper-right diagonal half) and actual numbers of mismatches (lower-left diagonal half) in the env V3-V5 sequences (C18:677bp and C78:683bp) of two FIV positive cats from China and representatives of each of the seven FIV subtypes with sequences on GenBank.

C18C78C171C172C174C176C180C181UK8Sendai1UK2DixonPPRPetalumaFDSSendai2USILCC36ShizuokaFukuokaLP3LP20
C18a94939493949495939393919090948180797979808282
C7845959597969494959493939092968080807980818181
C17153409594959494949493929190948180798079808080
C17244383896959696959493949192958179808079808181
C17453274034959495949492929091958078787878808080
C17651343636349494949493929191948180808080818181
C18051474232424295949393939091948079808080808080
C18148474534384233949393929092958079797980818181
UK856424038384243499594939092958079798079818181
A-Sendai150434946495159554493939092968079808079808080
A-UK256494951535151494455929090948079808079818181
A-Dixon66495549565549554754598992948180807981818180
A-PPR68707069797280787772728088918282828280818181
A-Petaluma73557065676267635865695691928179787980818180
A/B-FDS41314540424546424032455070608180808080818181
B-Sendai214314714014214814014114214415913813913714114195818082868585
B-USIL248914514714414815214114414415015215414613614914541808083878485
C-C1561541501481571481441521501471531561421591501381379980808080
C-C361531531461461541441441481451461501541391561471391351380808081
D-Shizuoka160147150154159146152152152153150150148142146131126151148928282
D-Fukuoka14413813914014113313613313514514314113914013910287139137708584
E-LP313814113914013913514213313514414614114213913810610914313613710895
E-LP2013614113913814113314013513914714414314014313910410413913313911535

a The GenBank Accession numbers of the China strains are C18 (KX646706), C78 (KX646707), C171 (KX904833), C172 (KX904834), C174 (KX904835), C176 (KX904836), C180 (KX904837) and C181 (KX904838), while those of previously reported FIV are: subtype A, UK8 (X69496), Sendai1 (D37813), UK2 (X69494), Dixon (L00607), PPR (M36968), Petaluma (M25381); subtype A/B, FDSydneyC36 (KP330229); subtype B, Sendai2 (D37814), USIL2489 (U11820); subtype C, C (AF474246), C36 (AY600517); subtype D, Shizuoka (D37811), Fukuoka (D37815); subtype E, LP3 (D84496), LP20 (D84498).

a The GenBank Accession numbers of the China strains are C18 (KX646706), C78 (KX646707), C171 (KX904833), C172 (KX904834), C174 (KX904835), C176 (KX904836), C180 (KX904837) and C181 (KX904838), while those of previously reported FIV are: subtype A, UK8 (X69496), Sendai1 (D37813), UK2 (X69494), Dixon (L00607), PPR (M36968), Petaluma (M25381); subtype A/B, FDSydneyC36 (KP330229); subtype B, Sendai2 (D37814), USIL2489 (U11820); subtype C, C (AF474246), C36 (AY600517); subtype D, Shizuoka (D37811), Fukuoka (D37815); subtype E, LP3 (D84496), LP20 (D84498). The phylogenetic trees we generated (Fig 1) that were based on the nucleotide sequences of our mainland China FIV strains and representative strains of FIV from GenBank clearly demonstrated that our Chinese strains were members of subtype A. In addition, the V3-V5 amino acid sequences of the envelop protein for FIV cats in this study were aligned with those of representative strains of FIV from GenBank (Fig 2).
Fig 2

Alignment of amino acid of FIV on envelop protein V3-V5 regions.

V3-V5 region amino acid sequences of FIV strains identified in this study (red font) were aligned with those of representatives FIV subtypes in GenBank (black for subtype A, blue for subtype A/B; green for subtype B; orange for subtype C, pink for subtype D, and brown for subtype E). Identical nucleotides at given positions are represented by dots (·), gaps are represented by dashes (-).

Alignment of amino acid of FIV on envelop protein V3-V5 regions.

V3-V5 region amino acid sequences of FIV strains identified in this study (red font) were aligned with those of representatives FIV subtypes in GenBank (black for subtype A, blue for subtype A/B; green for subtype B; orange for subtype C, pink for subtype D, and brown for subtype E). Identical nucleotides at given positions are represented by dots (·), gaps are represented by dashes (-).

Discussion

The results of our study confirm the presence of the FIV in mainland China and add to the known distribution range of the virus in the country. We found a low prevalence but the cats we studied were predominantly indoor pets that had little contact with other cats. Elsewhere, such cats also have a low prevalence of infection, for example 0.7% in the USA [24]. Why we found no infected cats in the shelter population from Yangzhou is unclear, as feral cats often have a high prevalence of FIV infection, for example 18% in the US [24]. Previous studies have shown cats infected with FIV do not have decreased longevity [27] and that it is only after relatively prolonged infection that immunosuppression occurs and clinical signs become apparent [28]. It was unexpected, then, that seven of the cats we found positive for FIV clinically ill although still relatively young (3 years of age or younger). Unfortunately, there was little or no laboratory data available on these cats and we were not able to establish what, if any, role the FIV infections might have played in the clinical signs that were reported. Previous studies have shown that PCRs for FIV provirus detection can have a wide range of sensitivities (41–93%) [29]. This relatively poor sensitivity might be as a result of the very low levels of provirus that can be present in infected cats, particularly in apparently healthy animals, but can also be due to variability in the proviral genome of the FIV; there can be up to 26% polymorphism between serotypes in the env and gag [30, 31]. Further, recombination with sometimes complex patterns resulting from co-infections or super-infections is also not uncommon in the FIVs [9, 32]. Because of the wide range of subtypes of FIVs and their high evolutionary rate, it is difficult to develop a PCR that is generic enough to amplify all subtypes and yet maintain high sensitivity [33]. The FRET-PCR we used against the gag has been shown to be sensitive, detecting single copies of the target, and capable of differentiating FIV subtypes A, B, C, D and E [24]. Similarly, the primers we developed against the V1-V2 region of the first segment of the env gene amplified subtypes A to E and enabled their differentiation with sequencing. We could not establish if our primers amplified subtype F and subtype U-NZenv as there are no sequence data for this region on GenBank for these two serotypes. There is sequence data, however, for the V3-V5 region of all the FIV subtypes and the primers we developed for this second segment of the env were capable of detecting all subtypes, that is A to F and also U-NZenv. The PCRs we performed in our study thus enabled us to detect low copy numbers of FIV and also to detect all the recognized subtypes. In our study, all the FIV positive isolates we detected belonged to subtype A which occurs widely around the world with most isolates being from Australia, New Zealand, North America, South Africa and Europe [10, 34]. Isolates from countries closer to mainland China have included subtypes A, B, C and D from Japan [14], subtype C from Korea and Vietnam [13, 35], and subtype D from Thailand [36]. Our description of subtype A in mainland China is thus the first description of this subtype in the country and, to the best of our knowledge, on the mainland of Asia. Of note is our finding that the sequences of the second segment of the env in three of our mainland China FIV strains (C18, C78 and C181) were very similar to the FDSydneyC36 (41, 31 and 42 mismatches, respectively) (Table 3, Fig 2). The sequences of the first segment of the env, however, were relatively distant (91, 91 and 98 mismatches, respectively), being more closely aligned with representatives of the FIV subtype B (Table 2, Fig 2). This difference is explained by the fact that the FDSydneyC36 strain, from a cat immunized with a commercial FIV vaccine [26], is a recombinant strain of FIV, subtype A/B. The second segment of the env is assigned to subtype A while the first segment is assigned to subtype B. Our findings of FIV subtype A and the serological evidence of infections presented by Cong et al. [23] should alert Chinese veterinarians to the possibility of infections in their feline patients. Although clinical signs resulting from FIV infection are highly variable and unpredictable, cats infected with subtype A have been found to remain asymptomatic for longer and have lower viral loads than cats infected with subtype C [34, 37, 38]. The subtype A FIV strains are often neurotrophic and can produce neurological signs, most commonly behavioral changes but also seizures, paresis, multifocal motor abnormalities, impaired learning and disrupted sleep patterns [5]. Currently there is only one registered FIV vaccine which is composed of two FIV subtypes, A and D. The vaccine is reported to confer protection against subtypes A, B and D and might then be useful in mainland China where [32, 39], to the best of our knowledge, vaccination is seldom if ever performed. A recent study, however, has shown the vaccine does not confer solid protection and breakthroughs were found with FIV subtypes A, F, A/F and D/F [40]. Further studies on the usefulness of vaccination under conditions of natural challenge are required, particularly in Asian countries where subtype C is prevalent. In conclusion, our study has shown that FIV subtype A occurs in mainland China and continental Asia. Larger studies are indicated to further determine the subtypes present in the region which will facilitate the development of accurate diagnostic tools and control programs.
  37 in total

1.  Phylogenetic analyses of Texas isolates indicate an evolving subtype of the clade B feline immunodeficiency viruses.

Authors:  Eric A Weaver; Ellen W Collisson; Margaret Slater; Guan Zhu
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Accuracy of polymerase chain reaction assays for diagnosis of feline immunodeficiency virus infection in cats.

Authors:  P Cynda Crawford; Margaret R Slater; Julie K Levy
Journal:  J Am Vet Med Assoc       Date:  2005-05-01       Impact factor: 1.936

Review 3.  Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.

Authors:  Ruiyu Pu; James Coleman; James Coisman; Eiji Sato; Taishi Tanabe; Maki Arai; Janet K Yamamoto
Journal:  J Feline Med Surg       Date:  2005-02       Impact factor: 2.015

4.  Phylogenetic analysis of Vietnamese isolates of feline immunodeficiency virus: genetic diversity of subtype C.

Authors:  K Nakamura; Y Suzuki; K Ikeo; Y Ikeda; E Sato; N T P Nguyen; T Gojobori; T Mikami; T Miyazawa
Journal:  Arch Virol       Date:  2003-04       Impact factor: 2.574

Review 5.  Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.

Authors:  Janet K Yamamoto; Ruiyu Pu; Eiji Sato; Tsutomu Hohdatsu
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

6.  Seroepidemiological survey of feline retrovirus infections in cats in Taiwan in 1993 and 1994.

Authors:  J A Lin; M C Cheng; Y Inoshima; K Tomonaga; T Miyazawa; Y Tohya; K Toh; Y S Lu; T Mikami
Journal:  J Vet Med Sci       Date:  1995-02       Impact factor: 1.267

7.  Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany.

Authors:  Sabine E Gleich; Stefan Krieger; Katrin Hartmann
Journal:  J Feline Med Surg       Date:  2009-07-18       Impact factor: 2.015

8.  Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1.

Authors:  Y Kawaguchi; J Norimine; T Miyazawa; C Kai; T Mikami
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

Review 9.  Molecular epidemiology of feline immunodeficiency virus in the domestic cat (Felis catus).

Authors:  Jessica J Hayward; Allen G Rodrigo
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

10.  Replication properties of clade A/C chimeric feline immunodeficiency viruses and evaluation of infection kinetics in the domestic cat.

Authors:  Sohela de Rozìeres; Jesse Thompson; Magnus Sundstrom; Julia Gruber; Debora S Stump; Aymeric P de Parseval; Sue VandeWoude; John H Elder
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

View more
  3 in total

1.  The first feline immunodeficiency virus from Siberian tigers (Panthera tigris altaica) in northeastern China.

Authors:  Enqi Liu; Liying Ma; Shuping Huang; Dan You; Lijun Guo; Xiang Li; Haitao Xu; Dan Liu; Hongliang Chai; Yajun Wang
Journal:  Arch Virol       Date:  2022-01-22       Impact factor: 2.574

2.  Molecular epidemiology of type I and II feline coronavirus from cats with suspected feline infectious peritonitis in China between 2019 and 2021.

Authors:  Lishan Lin; Dawei Yao; Lei Wu; Rubin Fan; Yang Liu; Zhenlei Zhou
Journal:  Arch Virol       Date:  2021-11-05       Impact factor: 2.574

3.  Decreased Sensitivity of the Serological Detection of Feline Immunodeficiency Virus Infection Potentially Due to Imported Genetic Variants.

Authors:  Julia Frankenfeld; Theres Meili; Marina L Meli; Barbara Riond; A Katrin Helfer-Hungerbuehler; Eva Bönzli; Benita Pineroli; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2019-07-31       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.